TABLE 1.

Clinical Characteristics and Imaging Results of Patients (n = 32)

Patient no.	Sex	Age (y)	NYHA classification	Body mass index	Brain natriuretic peptide (fmol/mL)	LV EF^* (%)	LV end-diastolic diameter^* (mm)
1	F	40	IV	19.8	879	27	69
2	M	51	IV	16.8	2,679	19	77
3	M	60	IV	24.7	1,601	27	71
4	M	44	III	26.4	2,201	40	58
5	F	54	IV	16.9	4,635	20	79
6	F	48	IV	20.0	3,742	20	54
7	M	60	IV	18.0	2,379	24	59
8	M	55	IV	27.4	1,211	41	57
9	M	71	III	22.3	974	37	56
10	M	18	IV	16.7	4,667	22	64
11	M	28	IV	29.6	4,393	17	60
12	F	38	III	20.1	1,605	36	60
13	M	61	III	27.1	1,098	42	57
14	F	72	IV	21.3	5,216	32	63
15	M	33	IV	20.8	2,828	26	72
16	M	53	IV	22.7	1,808	33	67
17	M	23	IV	17.1	561	18	68
18	M	33	IV	25.9	3,743	35	70
19	M	43	IV	21.4	1,669	18	65
20	M	58	IV	17.6	4,063	36	70
21	F	55	IV	24.0	972	20	65
22	M	64	IV	20.2	3,733	23	80
23	M	60	IV	24.8	1,102	33	65
24	M	52	IV	18.3	539	29	73
25	M	61	IV	26.3	2,892	32	65
26	F	68	IV	20.9	713	21	60
27	M	42	IV	26.6	1,747	25	60
28	M	67	IV	25.2	625	36	60
29	F	53	IV	23.4	2,570	31	71
30	M	56	IV	25.3	1,180	20	66
31	M	68	IV	27.5	2,079	35	66
32	M	53	IV	26.2	679	35	60